Explores miR-106b-5p's role in osteoporosis, suggesting a potential biomarker and target for treatment.
BACKGROUND/AIM: This study aimed to explore the expression, function, and regulatory mechanism of exosomal miR-106b-5p in osteoporosis (OP), to identify a novel diagnostic biomarkers and therapeutic targets. MATERIALS AND METHODS: . healthy controls=139:139) to identify OP-associated miRNAs. Lentivirus-infected MC3T3-E1 and RAW264.7 cells were used to investigate the impact of upregulated miR-106b-5p on the proliferation, apoptosis, and differentiation of osteoblasts and osteoclasts, respectively. Target genes were predicted via bioinformatics. RESULTS: genes. CONCLUSION: to suppress bone formation and enhance resorption, representing a potential diagnostic biomarker and therapeutic target.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: